Učitavanje...
Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity.Obje...
Spremljeno u:
Izdano u: | Colombia Médica |
---|---|
Glavni autori: | , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Universidad del Valle
2021
|
Teme: | |
Online pristup: | https://www.redalyc.org/articulo.oa?id=28366572004 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|